The monoclonal antibodies market which was USD 180.5 billion in 2021 surpasses USD 493.61 billion by 2029, exhibiting a CAGR of 13.40% in the forecasted period.
The monoclonal antibodies market which was USD 180.5 billion in 2021 surpasses USD 493.61 billion by 2029, exhibiting a CAGR of 13.40% in the forecasted period.
The monoclonal antibodies market which was USD 180.5 billion in 2021 surpasses USD 493.61 billion by 2029, exhibiting a CAGR of 13.40% in the forecasted period.